Related by context. All words. (Click for frequent words.) 76 Androxal ® 69 Androxal TM 67 hypogonadal men 67 secondary hypogonadism 67 Proellex 66 TBC# 65 Ophena TM 65 Triolex 65 teduglutide 65 Capesaris 63 GATTEX 63 PROMACTA 63 Phenoptin 63 alvimopan 63 decitabine 63 urocortin 2 63 eltrombopag 63 Zoraxel 63 ataluren 63 Anturol TM 62 otelixizumab 62 CoFactor 62 Zerenex 62 Chrysalin 62 LibiGel ® 62 Phase IIB 62 vilazodone 62 MYDICAR ® 62 cangrelor 62 bazedoxifene 62 ZOLINZA 61 phase IIa clinical 61 registrational 61 Stedivaze 61 ISIS # 61 Nasulin 61 avanafil 61 elagolix 61 Traficet EN 61 tezampanel 61 R#/MEM # 61 PS# [001] 61 azficel T 61 NEBIDO 61 RSD# 61 RDEA# 61 Ophena 61 pomalidomide 61 ELND# 61 Marqibo 61 LEUKINE 61 Mipomersen 61 pradefovir 61 APF# 61 YONDELIS 61 Plicera 61 EOquin 61 PREOS 61 lintuzumab 61 CIMZIA ™ 61 Azedra 61 Vilazodone 60 AZILECT R 60 Aurexis 60 MYDICAR 60 Octreolin 60 ATL# [001] 60 enzastaurin 60 Archexin 60 Apoptone 60 Menerba 60 thymalfasin 60 C1 INH 60 ONTAK 60 Bezielle 60 orBec 60 tecarfarin 60 Panzem R NCD 60 pharmacodynamic properties 60 MGCD# [001] 60 alvespimycin 60 elacytarabine 60 Chemophase 60 lomitapide 60 ELACYT 60 ularitide 60 sapacitabine 60 Fibrillex TM 60 Onrigin 60 Nebido 60 Generx 60 INCB# [002] 60 fenofibric acid 60 Serdaxin 60 goserelin 60 NGX# 60 cannabinor 60 Targretin 60 PRX # 60 bremelanotide 60 desvenlafaxine 60 ozarelix 60 maribavir 60 Amrubicin 60 elotuzumab 60 Elagolix 59 Aflibercept 59 Symadex 59 T Pred 59 eculizumab 59 Ozarelix 59 RSD# oral 59 BENICAR HCT 59 HuMax CD4 59 nalbuphine ER 59 Plenaxis TM 59 Tekamlo 59 INT# [002] 59 methylnaltrexone 59 Allovectin 7 R 59 QNEXA 59 HuLuc# 59 ACAPODENE 59 APOPTONE 59 lesinurad 59 Torisel 59 EOquin TM 59 FOLOTYN 59 Darusentan 59 TELCYTA 59 Amigal 59 eniluracil 59 selective androgen receptor modulator 59 PRISTIQ 59 ambrisentan 59 balsalazide tablet 59 Elocalcitol 59 prostate cancer CRPC 59 OncoVEX GM CSF 59 VA# [002] 59 PDE4 inhibitor 59 blinatumomab 59 vernakalant 59 Proellex TM 59 teriflunomide 59 posaconazole 59 metaglidasen 59 torezolid phosphate 59 riociguat 59 rhThrombin 59 Sym# 59 AVODART 59 6R BH4 59 atacicept 59 EFAPROXYN 59 PROVENGE sipuleucel T 59 Trofex 59 ganetespib 59 JAK inhibitor 59 CORLUX 59 CCX# 59 SNT MC# 59 INCB# [001] 59 SILENOR TM 59 pharmacokinetic characteristics 59 pharmacokinetic PK 59 Raptiva ® 59 Corlux 59 GFT# 59 metastatic castration resistant 59 PLK1 SNALP 59 BLA filing 59 BCX# 59 ofatumumab 59 PRT# 59 Acapodene 59 Gabapentin GR 59 AMR# 59 SomatoKine 59 pharmacodynamic effects 59 Anturol 58 clinical trials Multikine 58 castrate resistant prostate cancer 58 tesmilifene 58 liprotamase 58 Pirfenidone 58 AZILECT ® 58 Cetrorelix 58 ORMD 58 metastatic hormone refractory 58 Alzhemed TM 58 Neurodex 58 OMS#HP 58 tocilizumab 58 glufosfamide 58 Emezine 58 EndoTAG TM -1 58 CINQUIL 58 GSK# [001] 58 PSN# [002] 58 veltuzumab 58 bosentan 58 Phase 2b study 58 apremilast 58 Phase Ib study 58 sorafenib Nexavar 58 axitinib 58 omecamtiv mecarbil 58 lixisenatide 58 TRIOLEX 58 OvaRex ® MAb 58 Cloretazine 58 rilonacept 58 NPSP# 58 OHR/AVR# 58 Posiphen 58 placebo controlled clinical 58 calcitonin 58 Vascugel 58 EVIZON 58 Xanafide 58 DXL# 58 ABILIFY ® 58 Golimumab 58 ILUVIEN ® 58 ZYBRESTAT fosbretabulin 58 tanespimycin 58 febuxostat 58 TOCOSOL Paclitaxel 58 VAPRISOL 58 PREOS R 58 bardoxolone 58 herpetic keratitis 58 baminercept 58 preclinically 58 sitaxsentan 58 Desmoteplase 58 GnRH antagonist 58 FOLOTYN ® 58 nebivolol 58 LibiGel Phase III 58 eprotirome 58 GAMMAGARD 58 RhuDex 58 rNAPc2 58 pralatrexate 58 custirsen 58 AZOR 58 rHuPH# 58 galiximab 58 IPLEX 58 Revimmune 58 azacitidine 58 Dacogen injection 58 COPAXONE ® 58 Amplimexon 58 Phase III Pivotal 58 HuMax CD# 58 desvenlafaxine succinate 58 LymphoStat B 58 RG# [001] 58 RIGScan CR 58 FIRMAGON R 58 Dasatinib 58 DDP# 58 Pivotal Phase III 58 PROCHYMAL 58 phase IIb clinical 58 FASLODEX 58 alteplase 58 KYNAPID 58 PXD# 58 ospemifene 58 Cinryze ™ 58 Zelrix 58 Degarelix 58 Caprospinol 58 diabetic neuropathic pain 58 aclidinium 58 Glypromate 58 CCR5 antagonist 58 Bicifadine 58 Ostarine 58 mRCC 58 CEQ# 58 forodesine 58 MultiStem 58 Diamyd R 58 MDV# 58 HER2 positive metastatic breast 58 ruxolitinib 58 TG# [003] 58 KNS # 58 Diamyd ® 58 bicalutamide 58 Viramidine 58 ALISTA 57 #ME# 57 MAGE A3 ASCI 57 cetrorelix 57 ZYBRESTAT 57 VELCADE melphalan 57 Targretin capsules 57 rALLy trial 57 vidofludimus 57 olmesartan 57 Phase IIa trial 57 HoFH 57 ostarine 57 telbivudine 57 Ambrisentan 57 anidulafungin 57 Sanctura XR 57 reslizumab 57 DAVANAT 57 Genz # 57 teplizumab 57 mipomersen 57 MAXY G# 57 subcutaneously administered 57 Increlex R 57 Cethrin 57 CIMZIA TM 57 Naproxcinod 57 SILENOR 57 Cleviprex TM clevidipine 57 TH# [003] 57 nitazoxanide 57 MOZOBIL 57 LibiGel 57 Cloretazine R VNP#M 57 CTAP# Capsules 57 Technosphere Insulin 57 CR# vcMMAE 57 active comparator 57 ORENCIA R 57 TREDAPTIVE 57 rFIXFc 57 PEG SN# 57 canakinumab 57 Phase 2a trial 57 LidoPAIN SP 57 ThGRF 57 pitavastatin 57 KRN# 57 Clolar ® 57 mycophenolate mofetil 57 Anturol ® 57 pivotal Phase III 57 PRX# 57 SAPHRIS 57 randomized Phase 2b 57 Evoltra 57 mapatumumab 57 NUVIGIL 57 FTY# 57 Phase Ib II 57 Phase III Clinical Trials 57 Q#IR 57 phase IIa 57 AGGRASTAT ® 57 Urocidin 57 Rhucin 57 LCP Tacro 57 Rasagiline 57 Pimavanserin 57 Genasense R oblimersen 57 PRTX 57 CINTREDEKIN BESUDOTOX 57 omacetaxine 57 talactoferrin 57 Prochymal 57 octreotide implant 57 Aclidinium 57 Phase IIIb clinical 57 AEG# 57 NLX P# 57 ustekinumab 57 tamibarotene 57 BRIM3 57 BAY #-# 57 vosaroxin 57 PF # [001] 57 SinuNase 57 TELINTRA 57 daclizumab 57 perifosine 57 OXi# 57 Omigard 57 ProSavin 57 EDEMA3 57 valopicitabine 57 lanthanum carbonate 57 L MTP PE 57 XmAb# 57 amrubicin 57 PD LID 57 prGCD 57 liposomal formulation 57 Clonicel 57 AzaSite Plus 57 hGH CTP 57 SEPET TM 57 favorable pharmacokinetic profile 57 TRO# 57 acyclovir Lauriad R 57 PRADAXA 57 Teriparatide 57 briakinumab 57 Civacir 57 HGS ETR1 57 Xinlay 57 visilizumab 57 CCR9 antagonist 57 systemically administered 57 Tavocept 57 Noxafil 57 BLA submission 57 relapsed MM 57 AGGRASTAT R 57 ADAGIO study 57 Tamibarotene 57 JANUVIA 57 cilengitide 57 INCB# [003] 57 GLP toxicology studies 57 PHX# 57 analgesic efficacy 57 Troxatyl 57 YERVOY 57 Bronchitol 57 CRMD# 57 MabCampath 57 DU #b 57 PMX # 57 oral prodrug 57 icatibant 57 hypoparathyroidism 57 Augment Injectable 57 tafamidis 57 Combidex 57 vasomotor symptoms 57 CYT# 57 MERLIN TIMI 57 Restanza 57 Rebif ® 57 Panzem R 57 IL# PE#QQR 57 Catena ® 57 Phase 2b trial 57 Fampridine SR 56 LibiGel testosterone gel 56 AXIRON ™ 56 LY# [003] 56 Axiron 56 Exherin TM 56 Phase III Clinical Trial 56 ELADUR 56 THALOMID 56 Vasovist 56 Elitek 56 Aryplase 56 GALNS 56 Dapagliflozin 56 cobiprostone 56 teriparatide 56 registrational trial 56 NATRECOR R 56 Zyclara 56 Epanova 56 ISTODAX 56 Northera 56 DR Cysteamine 56 PrevOnco 56 Cellegesic 56 Tarceva TM 56 lasofoxifene 56 AEGR 56 Phase Ib 56 DEB# 56 pegloticase 56 dosing cohort 56 Firazyr 56 REMICADE ® 56 interferon beta 1b 56 CBLC# 56 degarelix 56 pharmacokinetic PK profile 56 belinostat 56 Dalbavancin 56 Riquent 56 IRESSA 56 clinical pharmacology studies 56 prostate cancer HRPC 56 Zavesca R 56 pharmacokinetic PK study 56 terlipressin 56 CCX# B 56 IMiDs 56 Rescula 56 oral ridaforolimus 56 Hypoactive Sexual Desire Disorder 56 sargramostim 56 Aplidin 56 EpiCeram TM 56 Entereg R 56 relapsing remitting multiple sclerosis 56 Mylotarg 56 Betaferon ® 56 pegaptanib 56 esophageal candidiasis 56 darifenacin 56 Silodosin 56 Fibrin Pad 56 NV1FGF 56 PCK# 56 Myocet 56 oxymorphone ER 56 XGEVA 56 Icatibant 56 Zenvia 56 QuadraSphere 56 orally bioavailable 56 Loramyc R 56 ULORIC 56 Prodarsan 56 microplasmin 56 QLT# 56 adecatumumab 56 AFRESA 56 PSMA ADC 56 dexanabinol 56 lucinactant 56 STELARA 56 refractory gout 56 Lysteda 56 EP #R 56 muraglitazar 56 hereditary deficiency 56 rindopepimut 56 TORISEL 56 Fabry Disease 56 Ventavis 56 VIDAZA 56 Dyloject TM 56 pharmacokinetic profile 56 Cethromycin 56 lapatinib Tykerb 56 heterozygous FH 56 oral FTY# 56 trospium 56 uricase 56 Renvela 56 Guanilib 56 Increlex ® 56 ORENCIA ® 56 ILLUMINATE 56 metastatic HRPC 56 Alocrest 56 alagebrium 56 Tasimelteon 56 adenosine injection 56 serum testosterone 56 LHRH antagonist 56 TRISENOX 56 Vicriviroc 56 oral rivaroxaban 56 LUVENIQ 56 oral bioavailability 56 SUTENT 56 brivaracetam 56 Lodotra 56 TREANDA 56 anti arrhythmic 56 CYCLOSET 56 Procoralan 56 VIAject R 56 CA4P 56 Tezampanel 56 MIRCERA 56 Frova ® 56 Solorel 56 prucalopride 56 SinuNase TM 56 silodosin 56 menadione 56 ICA # 56 GLP1 agonist 56 SPIRIVA HandiHaler 56 schizophrenia CIAS 56 PROSTVAC TM 56 DASISION 56 adipiplon 56 Phase 1b trial 56 Hyphanox 56 Cloretazine ® 56 dosage regimens 56 naproxcinod 56 GnRH agonists 56 Duromist ™ 56 ATryn R 56 Jevtana 56 phase IIb 56 Vernakalant 56 Liraglutide 56 X Excite 56 ONCONASE R 56 IDX# 56 Phase IIa clinical 56 Onconase 56 investigational antiplatelet agent 56 efficacy endpoints 56 Preos 56 bifeprunox 56 HGS ETR2 56 NP2 Enkephalin 56 Avanafil 56 pegylated interferons 56 Fablyn 56 LEVADEX ™ 56 ranolazine 56 lumiliximab 56 dextofisopam 56 Phase III clinical 56 Phase IIa trials 56 tiapamil 56 sorafenib tablets 56 ONGLYZA 56 ARCOXIA 56 TYKERB 56 PREZISTA r 56 Avastin bevacizumab 56 omega interferon 56 Aclasta 56 Estradiol 56 vicriviroc 56 AGHD 56 antithrombotic 56 hormone refractory prostate cancer 56 LUCENTIS 55 plasma pharmacokinetics 55 BRIM2 55 Genasense ® oblimersen 55 ROCKET AF 55 CORT # 55 maximally tolerated dose 55 pharmacodynamic profile 55 Panzem 55 AERx iDMS 55 dose escalation phase 55 MoxDuo IR 55 E2F Decoy 55 investigational drug 55 Toremifene 55 vandetanib 55 Eltrombopag 55 TOLAMBA 55 lupus nephritis 55 Delatestryl 55 RGB # 55 betrixaban 55 PegIntron 55 catheter occlusion 55 Tyrima 55 Reverset 55 IRX 2 55 interferon gamma 1b 55 aliskiren 55 Velcade bortezomib 55 Personalized Immunotherapy 55 pertuzumab 55 LY# [002] 55 coadministration 55 EDEMA4 55 trabectedin 55 davunetide intranasal AL 55 Æterna Zentaris 55 mertansine 55 INC# 55 Multaq R 55 Inhalation Solution 55 Prodarsan ® 55 ACZ# 55 HQK 55 Cinryze TM 55 zileuton CR 55 TEMODAL 55 STRIDE PD 55 Synavive 55 incyclinide 55 CAPHOSOL 55 PLX PAD 55 Dextofisopam 55 Glufosfamide 55 lipid lowering therapy 55 statistically significant efficacy 55 LAF# 55 ATACAND 55 ALGRX 55 ferumoxytol 55 UPLYSO 55 S/GSK# 55 Oral NKTR 55 dose escalation clinical 55 paclitaxel eluting stents 55 valsartan 55 hoFH 55 bicifadine 55 atherothrombotic events 55 temsirolimus 55 aflibercept VEGF Trap 55 HCV protease inhibitors 55 Prestara 55 blinded randomized placebo controlled 55 HepeX B 55 Rivaroxaban 55 PDX pralatrexate 55 GnRH agonist 55 Cardio Vascu Grow 55 rhIGF-I/rhIGFBP-3 55 pain palliation 55 GLYX 55 VPRIV 55 CANCIDAS 55 bazedoxifene conjugated estrogens 55 HuMax EGFr 55 romidepsin 55 denufosol 55 relapsed ovarian cancer 55 GATTEX TM 55 Perifosine 55 COPAXONE R 55 linaclotide 55 Neo Kidney Augment 55 panitumumab 55 Vaprisol 55 Phase 2a clinical 55 GATTEX ® 55 GED aPC 55 GW# [003] 55 azilsartan medoxomil 55 MACUGEN 55 Welchol 55 OMAPRO 55 Sulonex 55 Cinryze 55 fosbretabulin 55 celgosivir 55 confirmatory Phase III 55 ALTU 55 Zybrestat 55 topical NSAID 55 Pruvel 55 noninferiority 55 alicaforsen enema 55 darusentan 55 ATPace TM 55 REMINYL ® 55 Elafin 55 IV APAP 55 darapladib 55 fenofibrate 55 SparVax TM 55 TYZEKA 55 huC# DM4 55 diarrhea predominant irritable 55 AVE# 55 Aviptadil 55 alpha blocker 55 NATRECOR ® 55 Heplisav 55 abiraterone acetate 55 Lu AA# 55 tramiprosate 55 AeroLEF TM 55 MyoCell 55 Sandostatin LAR 55 peginesatide 55 PEGINTRON TM 55 pharmacodynamic profiles 55 olaparib 55 metastatic castrate resistant 55 Phase III HEAT 55 Allovectin 7 ® 55 pharmacokinetics pharmacodynamics 55 Teriflunomide 55 Raptiva R 55 SEROQUEL XR 55 TACI Ig 55 Phase IIb 55 squalamine 55 Phase 2a 55 ASA# 55 indacaterol 55 PEARL SC 55 Onrigin TM 55 DPP4 55 adalimumab 55 viral kinetics 55 postoperative ileus POI 55 initiate Phase 1b 55 sunitinib malate 55 Rasilez Tekturna 55 PrevOnco ™ 55 Phase IIb trials 55 virus HCV protease inhibitor 55 OMAPRO ™ 55 sulodexide 55 rFVIIa 55 sunitinib 55 insulin detemir 55 oral calcitonin 55 iniparib 55 relapsed multiple myeloma 55 FACTIVE tablets 55 IV Busulfex 55 Romiplostim 55 caspofungin 55 mTOR inhibitor 55 NOXAFIL 55 Ceplene 55 APD# 55 APTIVUS 55 Phase III 55 AZX# 55 LEVADEX 55 Lixivaptan 55 HRPC 55 obatoclax 55 dose proportionality 55 Sprycel dasatinib 55 SPIRIT FIRST 55 HDL Selective Delipidation 55 MAXY VII 55 Telmisartan 55 tamoxifen therapy 55 blinded randomized 55 Relivar 55 ACTEMRA TM 55 masitinib 55 VIAject 55 Peyronie Disease 55 Phase Ia 55 antiarrhythmic drug 55 epothilone 55 mGluR5 NAM 55 PSD# 55 anticancer compound 55 tezampanel NGX# 55 HERmark 55 Aegerion 55 FOLFOX4 55 confirmatory clinical 55 Clevudine 55 Protelos 55 Veronate 55 ONTARGET 55 HEPLISAV 55 FIRAZYR 55 AQ4N 55 Indaflex TM 55 BST CarGel R 55 #mg dose [001] 55 Fx #A 55 Anidulafungin 55 PRIMO CABG 55 anti leukemic 55 nonclinical studies 55 viral kinetic 55 Cimzia R 55 tramiprosate Alzhemed TM 55 Zenvia Phase III 55 NDA resubmission 55 dopamine partial agonist 55 integrase inhibitor 55 neratinib 55 noninfectious uveitis 55 Cethrin R 55 Sapacitabine 55 Phase 2b clinical 55 Topical Interferon Alpha 2b 55 Fibrillex 55 Pivotal Phase 55 NN# [001] 55 fluvastatin 55 RhuDex ® 55 ancrod 54 DP b# 54 MEVACOR 54 mifamurtide 54 ONGLYZA ™ 54 atrasentan 54 CaPre TM 54 proprietary transdermal patch 54 MAA submission 54 aripiprazole 54 tesetaxel 54 REVLIMID lenalidomide 54 abatacept 54 cabazitaxel 54 PEGylated anti 54 Ereska 54 velaglucerase alfa 54 Taxotere ® 54 LT NS# 54 phase Ib 54 Tolvaptan 54 BENLYSTA ® 54 Velac 54 Zemplar Capsules 54 ARIXTRA 54 MAXY alpha 54 ZYFLO CR 54 Surfaxin LS 54 Factor IX 54 hylan GF 54 Simulect 54 SCH # 54 MEK inhibitor RDEA# 54 pharmacokinetic equivalence 54 metastatic renal cell carcinoma 54 albinterferon alfa 2b 54 pharmacokinetic properties 54 Meets Primary Endpoint 54 ATryn ® 54 Laquinimod 54 refractory angina 54 lubiprostone 54 delivers fluocinolone acetonide FA 54 Phase #b/#a 54 Carfilzomib 54 Huntexil 54 etanercept 54 hormone LHRH antagonist 54 tenofovir emtricitabine 54 ApoB SNALP 54 Adalimumab 54 Certican 54 Clolar 54 docetaxel Taxotere ® 54 Phase 1b 54 NVA# 54 Imprime PGG 54 INVEGA ® 54 crizotinib PF # 54 Promacta 54 Eculizumab 54 Virulizin R 54 pivotal Phase 54 Amitiza 54 Ocrelizumab 54 DCCR 54 ACCORD Lipid 54 pexelizumab 54 fidaxomicin 54 Advagraf 54 pharmacodynamic 54 pharmacokinetics PK 54 PANVAC VF 54 intermittent dosing 54 Dacogen 54 APTIVUS r 54 phase IIb trial 54 pseudobulbar affect PBA 54 Kepivance 54 voreloxin 54 Zirgan 54 flutamide 54 MGd 54 relapsed AML 54 CDP# 54 AVN# [001] 54 ADVEXIN 54 Phenserine 54 Phase 1a clinical 54 Sitagliptin 54 IND submission 54 Egrifta 54 ritonavir boosting 54 AZD# 54 Pixuvri 54 HCV RESPOND 2 54 bosutinib 54 ALN PCS 54 Microplasmin 54 Cushing Syndrome 54 oral talactoferrin 54 Arranon 54 Phase IIb clinical 54 romiplostim 54 INTEGRILIN 54 budesonide foam 54 Azilect ® 54 docetaxel chemotherapy 54 Soliris TM eculizumab 54 Adlea 54 FAMPYRA 54 ecallantide 54 liraglutide